Brief report: Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

Medical and Pediatric Oncology

Volumn 37, Issue 2, 2001, Pages 153-154

  Kitazawa, Junichi ^a   Ito, Etsuro ^b   Arai, Koji ^c   Yokoyama, Masaru ^a   Fukayama, Masashi ^b   Imashuku, Shinsaku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

EBV; Etoposide; Histiocytosis; Secondary leukemia

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; ANTINEOPLASTIC AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RISK; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; HUMAN; MALIGNANT HISTIOCYTOSIS; METASTASIS; MYELODYSPLASTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; HISTIOCYTOSIS; SECOND CANCER; VIRUS INFECTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD, PRESCHOOL; CYCLOSPORINE; DEXAMETHASONE; EPSTEIN-BARR VIRUS INFECTIONS; ETOPOSIDE; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOCYTIC, ACUTE; NEOPLASMS, SECOND PRIMARY;

EID: 0035432094     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1189     Document Type: Article

References (10)

1. Infection- and malignancy-associated hemophagocytic syndromes. Secondary -hemophagocytic lymphohistiocytosis
2. Effective control of Epstein-Bart virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy
3. HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis
4. Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87
5. Therapy-related AML after successful chemotherapy with low dose etoposide for virus-associated hemophagocytic syndrome
6. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia
7. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide
8. L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins
9. Secondary acute myelogenous leukemia following safe exposure to etoposide
10. Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis